Thiazolidinediones for type 2 diabetes - New agents reduce insulin resistance but need long term clinical trials

被引：47

作者：

Krentz, AJ ^{[1
]}

Bailey, CJ

Melander, A

机构：

[1] Southampton Gen Hosp, Southampton SO16 6YD, Hants, England

[2] Aston Univ, Dept Pharmaceut Sci, Birmingham B4 7ET, W Midlands, England

[3] Malmo Univ Hosp, Med Res Ctr, SE-20502 Malmo, Sweden

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2000年 / 321卷 / 7256期

基金：

英国惠康基金;

关键词：

D O I：

10.1136/bmj.321.7256.252

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：252 / 253

页数：2

共 13 条

[1]

Bailey CJ, 2000, DIABETIC MED, V17, P414

[2]

BAILEY CJ, 2000, PRACTICAL DIABETES I, V17, P1

[3] Thiazolidinediones: a new class of antidiabetic drugs [J].

Day, C .

DIABETIC MEDICINE, 1999, 16 (03) :179-192

[4] EARLY METABOLIC DEFECTS IN PERSONS AT INCREASED RISK FOR NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].

ERIKSSON, J ;

FRANSSILAKALLUNKI, A ;

EKSTRAND, A ;

SALORANTA, C ;

WIDEN, E ;

SCHALIN, C ;

GROOP, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (06) :337-343

[5] Fortnightly review - Insulin resistance [J].

Krentz, AJ .

BMJ-BRITISH MEDICAL JOURNAL, 1996, 313 (7069) :1385-1389

[6] The perils of portliness - Causes and consequences of visceral adiposity [J].

Montagne, CT ;

O'Rahilly, S .

DIABETES, 2000, 49 (06) :883-888

[7] Diabetes: A time for excitement - and concern [J].

Orchard, T .

BRITISH MEDICAL JOURNAL, 1998, 317 (7160) :691-692

[8] ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].

REAVEN, GM .

DIABETES, 1988, 37 (12) :1595-1607

[9] Thiazolidinediones: an update [J].

Schoonjans, K ;

Auwerx, J .

LANCET, 2000, 355 (9208) :1008-1010

[10]

*SMITHKL BEECH PHA, 2000, AV ROS SUMM PROD CHA

← 1 2 →